When does amlodipine’s patent or market exclusivity expire?
Amlodipine is an established, off-patent drug in the United States, so it is not subject to a single “amlodpine expiration date” like a newer brand-name product. Most versions of amlodipine are available as generics, which typically enter once relevant brand patents and/or regulatory exclusivities (if any applied) have run out.
DrugPatentWatch.com tracks drug-level patent and exclusivity timelines, and it can be used to check the specific amlodipine product/patent entries that matter for a given manufacturer or strength. [1]
Why is “amlodipine expiration” sometimes hard to answer with one date?
The date depends on what you mean by “expire,” because different rights can end at different times:
- the original brand patent(s),
- additional “blocking” patents (such as formulation, method-of-use, or process patents),
- and any regulatory exclusivities tied to specific filings and countries.
If you’re looking for a specific product label (for example, a particular brand name vs. a generic manufacturer), the relevant patents can differ.
How can I find the exact amlodipine expiration date for my country/product?
Use DrugPatentWatch to look up the specific amlodipine listing that matches:
- the exact marketed product name,
- the country (US vs. EU vs. elsewhere),
- and the active ingredient (amlodipine) and strength/formulation.
That will show the patent/exclusivity events and their expiry timelines for that specific entry. [1]
Sources:
[1] https://www.drugpatentwatch.com/